WE Global News

Find out why your website may be hurting conversions and what you can do to improve it.

AI has collapsed the cost of building a company — here's how to run lean, skip the Series A and keep control of what you build.

OpenAI just launched Work — and it could replace half your AI stack while cutting your software bill.

Chasing cost efficiency during a growth spurt feels smart — until it burns out the team that got you there.

How a pandemic forced one startup to abandon its original business, uncover a hidden infrastructure opportunity and ultimately position itself for an eight-figure acquisition.

Here are six questions investors are quietly asking before they ever mention your pitch deck.

Daniel Krynzel, founder of Big Balls Brotherhood, believes the greatest threat to an entrepreneur's performance isn't a lack of time. It's losing control of their attention before the workday even begins.

Brands are rushing into cultural moments, but without a clear role or real experience behind them, relevance can quickly turn into risk.

Workplace injuries cost businesses far more than most owners realize. Here's why.

Founder fatigue builds quietly — but the right habits and structure can prevent it.

The CEO of the largest bank in the U.S. minimized concerns about AI’s impact on jobs.

AI is driving unprecedented demand for industrial-scale electricity, water for cooling and physical real estate at a pace the global grid was never designed to handle.

Anna Hudick's engineering experience serves her well as an entrepreneur.

Look no further for your next great business idea.

AI can’t take over this part of the legal profession.

Before buying a franchise, ask the right questions about the brand’s track record, financial performance, support system and culture to determine whether it’s the right fit for your goals.

Days after a firebombing at Sam Altman's house, an intruder snuck into Anthropic's lobby to warn of a threat.

Non-traditional students are reshaping the future of higher education. Here's how.

Emerging markets are growing faster, cheaper to enter and largely ignored. Here's why that's a mistake.

Big pharma is making a big bet that a DMT nasal spray could succeed where daily Prozac pills fall short.